Cannara Biotech Inc. (TSX:LOVE)
Canada
· Delayed Price · Currency is CAD 1.840
-0.030 (-1.60%)
At close: Mar 9, 2026
Cannara Biotech Ratios and Metrics
Market cap in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | 2020 - 2018 |
| Market Capitalization | 182 | 165 | 61 | 90 | 118 | 149 | Upgrade
|
| Market Cap Growth | 60.42% | 168.86% | -32.29% | -23.64% | -20.54% | 112.60% | Upgrade
|
| Enterprise Value | 200 | 198 | 105 | 131 | 146 | 160 | Upgrade
|
| Last Close Price | 1.84 | 1.80 | 0.68 | 1.00 | 1.35 | 1.70 | Upgrade
|
| PE Ratio | 15.44 | 12.59 | 9.51 | 13.02 | 51.35 | - | Upgrade
|
| PS Ratio | 1.62 | 1.54 | 0.75 | 1.58 | 3.30 | 8.75 | Upgrade
|
| PB Ratio | 1.63 | 1.61 | 0.70 | 1.13 | 1.77 | 2.32 | Upgrade
|
| P/TBV Ratio | 1.63 | 1.61 | 0.70 | 1.13 | 1.77 | 2.32 | Upgrade
|
| P/FCF Ratio | 14.68 | 12.05 | 19.05 | - | - | - | Upgrade
|
| P/OCF Ratio | 8.21 | 8.22 | 5.73 | 15.29 | - | - | Upgrade
|
| EV/Sales Ratio | 1.78 | 1.84 | 1.28 | 2.29 | 4.07 | 9.40 | Upgrade
|
| EV/EBITDA Ratio | 7.45 | 7.04 | 7.62 | 7.92 | 16.91 | 58.11 | Upgrade
|
| EV/EBIT Ratio | 9.94 | 9.13 | 13.69 | 11.17 | 30.25 | 3041.19 | Upgrade
|
| EV/FCF Ratio | 16.16 | 14.47 | 32.55 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.31 | 0.41 | 0.55 | 0.57 | 0.73 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 1.30 | 1.47 | 3.45 | 2.75 | 5.54 | 7.15 | Upgrade
|
| Debt / FCF Ratio | 2.81 | 3.05 | 15.04 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.27 | 0.47 | 0.52 | 0.54 | 0.20 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.69 | 0.97 | 3.04 | 2.51 | 4.21 | 4.63 | Upgrade
|
| Net Debt / FCF Ratio | 1.48 | 1.99 | 12.98 | -10.46 | -1.68 | -0.38 | Upgrade
|
| Asset Turnover | 0.67 | 0.66 | 0.55 | 0.43 | 0.33 | 0.23 | Upgrade
|
| Inventory Turnover | 1.37 | 1.32 | 1.41 | 1.14 | 1.40 | 1.39 | Upgrade
|
| Quick Ratio | 1.01 | 0.83 | 0.73 | 0.70 | 1.75 | 1.63 | Upgrade
|
| Current Ratio | 2.70 | 2.40 | 2.50 | 2.44 | 3.46 | 2.82 | Upgrade
|
| Return on Equity (ROE) | 11.71% | 13.75% | 7.68% | 9.48% | 3.52% | -2.98% | Upgrade
|
| Return on Assets (ROA) | 7.51% | 8.37% | 3.23% | 5.48% | 2.77% | 0.04% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.73% | 12.08% | 6.09% | 10.45% | 5.36% | 0.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.10% | 16.10% | 6.00% | 9.70% | 4.20% | 0.10% | Upgrade
|
| Earnings Yield | 6.50% | 7.95% | 10.52% | 7.68% | 1.95% | -1.03% | Upgrade
|
| FCF Yield | 6.81% | 8.30% | 5.25% | -4.39% | -18.20% | -22.26% | Upgrade
|
| Buyback Yield / Dilution | -2.18% | -1.08% | -1.83% | -2.16% | -14.80% | -7.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.